Digital health firm Oviva is planning to roll out its digital diabetes treatment across Europe after securing $21 million of investment. The Series B round was led by Swiss growth investment firm MTIP ...

Zürich, Switzerland-based Oviva Health, developer of a dietary intervention delivery platform, has secured $12 million in Series A funding. Participants in the round include Albion Capital, Eight ...

BOSTON, April 29, 2025 /PRNewswire/ -- Granata Bio ("Granata") today announced the acquisition of Oviva Therapeutics, Inc. ("Oviva"), a pioneering women's health biotech company focused on advancing ...

ZURICH, Jan. 15, 2020 /PRNewswire/ -- Oviva, the leading digital provider of Type 2 diabetes treatment in Europe, has raised $21m in Series B funding. MTIP led the round, joined by Earlybird as new ...

Swiss digital therapy specialist Oviva has raised $21 million in second-round financing to help expand the use of smartphone-based tools designed to help people with diabetes manage their condition.

Oviva, the health tech startup that provides a digital solution for Type 2 diabetes treatment in Europe, has raised $21 million in Series B funding. Leading the round is MTIP, with participation by ...

Oviva, the digital health scaleup which provides diet and lifestyle coaching has announced that it has raised €67 million ($80m) in Series C funding to expand its digital diabetes treatment across ...